Glycyrrhizic acid attenuates CCl4-induced hepatocyte apoptosis in rats via a p53-mediated pathway

World Journal of Gastroenterology

Volumn 19, Issue 24, 2013, Pages 3781-3791

  Guo, Xiao Ling ^a   Liang, Bo ^a   Wang, Xue Wei ^a   Fan, Fu Gang ^a   Jin, Jing ^b   Lan, Rui ^b   Yang, Jing Hui ^a   Wang, Xiao Chun ^a   Jin, Lei ^a   Cao, Qin ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Glycyrrhizic acid; Liver fibrosis; Mitochondria; P53

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CASPASE 3; CASPASE 9; COLLAGEN FIBER; CYTOCHROME C; GLYCYRRHIZIC ACID; INHIBITOR OF APOPTOSIS PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER FUNCTION; MALE; MITOCHONDRION; NICK END LABELING; NONHUMAN; RAT; SCORING SYSTEM; STAINING; WESTERN BLOTTING;

EID: 84879596604     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i24.3781     Document Type: Article

References (58)

1. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002; 123: 1323-1330 [PMID: 12360492 DOI: 10.1053/gast.2002.35953]
2. Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 2004; 39: 273-278 [PMID: 14767974 DOI: 10.1002/hep.20051]
3. Kodama T, Takehara T, Hikita H, Shimizu S, Shigekawa M, Tsunematsu H, Li W, Miyagi T, Hosui A, Tatsumi T, Ishida H, Kanto T, Hiramatsu N, Kubota S, Takigawa M, Tomi-maru Y, Tomokuni A, Nagano H, Doki Y, Mori M, Hayashi N. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest 2011; 121: 3343-3356 [PMID: 21747166 DOI: 10.1172/JCI44957]
4. Inoue S, Browne G, Melino G, Cohen GM. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 2009; 16: 1053-1061 [PMID: 19325570 DOI: 10.1038/cdd.2009.29]
5. Panasiuk A, Dzieciol J, Panasiuk B, Prokopowicz D. Expression of p53, Bax and Bcl-2 proteins in hepatocytes in nonalcoholic fatty liver disease. World J Gastroenterol 2006; 12: 6198-6202 [PMID: 17036395]
6. Attallah AM, Shiha GE, Ismail H, Mansy SE, El-Sherbiny R, El-Dosoky I. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocel-lular carcinoma associated with chronic HCV infection. Clin Biochem 2009; 42: 455-461 [PMID: 19063876 DOI: 10.1016/ j.clinbiochem.2008.11.004]
7. Papakyriakou P, Tzardi M, Valatas V, Kanavaros P, Karydi E, Notas G, Xidakis C, Kouroumalis E. Apoptosis and apop-tosis related proteins in chronic viral liver disease. Apoptosis 2002; 7: 133-141 [PMID: 11865197]
8. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002; 2: 594-604 [PMID: 12154352 DOI: 10.1038/nrc864]
9. Chen LH, Hsu CY, Weng CF. Involvement of P53 and Bax/ Bad triggering apoptosis in thioacetamide-induced hepatic epithelial cells. World J Gastroenterol 2006; 12: 5175-5181 [PMID: 16937528]
10. Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev 2010; 90: 1165-1194 [PMID: 20664081 DOI: 10.1152/physrev.00061.2009]
11. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998; 95: 4997-5002 [PMID: 9560217 DOI: 10.1073/pnas.95.9.4997]
12. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 2000; 275: 31199-31203 [PMID: 10940292 DOI: 10.1074/jbc. C000405200]
13. Kappler M, Köhler T, Kampf C, Diestelkötter P, Würl P, Schmitz M, Bartel F, Lautenschläger C, Rieber EP, Schmidt H, Bache M, Taubert H, Meye A. Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer 2001; 95: 360-363 [PMID: 11668517]
14. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584 [PMID: 9859993 DOI: 10.1038/25141]
15. Fraser AG, James C, Evan GI, Hengartner MO. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol 1999; 9: 292-301 [PMID: 10209096 DOI: 10.1016/S0960-9822(99)80137-7]
16. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-470 [PMID: 11931755 DOI: 10.1016/S1097-2765(02)00482-3]
17. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5: 897-907 [PMID: 15520809 DOI: 10.1038/nrm1496]
18. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42 [PMID: 10929711 DOI: 10.1016/S0092-8674(00)00008-8]
19. Carter BZ, Mak DH, Schober WD, Koller E, Pinilla C, Vassi-lev LT, Reed JC, Andreeff M. Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML. Blood 2010; 115: 306-314 [PMID: 19897582 DOI: 10.1182/blood-2009-03-212563]
20. Liu JP, McIntosh H, Lin H. Chinese medicinal herbs for chronic hepatitis B. Cochrane Database Syst Rev 2001; (1): CD001940 [PMID: 11279742 DOI: 10.1002/14651858.CD001940]
21. Dang SS, Zhang X, Jia XL, Cheng YA, Song P, Liu EQ, He Q, Li ZF. Protective effects of emodin and astragalus polysac-charides on chronic hepatic injury in rats. Chin Med J (Engl) 2008; 121: 1010-1014 [PMID: 18706249]
22. Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Ar-manini D, Bielenberg J. Antiviral effects of Glycyrrhiza species. Phytother Res 2008; 22: 141-148 [PMID: 17886224 DOI: 10.1002/ptr.2295]
23. Kimura M, Watanabe H, Abo T. Selective activation of extrathymic T cells in the liver by glycyrrhizin. Biotherapy 1992; 5: 167-176 [PMID: 1419465 DOI: 10.1007/BF02171049]
24. Crance JM, Lévêque F, Biziagos E, van Cuyck-Gandré H, Jouan A, Deloince R. Studies on mechanism of action of glyc-yrrhizin against hepatitis A virus replication in vitro. Antiviral Res 1994; 23: 63-76 [PMID: 8141593 DOI: 10.1016/0166-354 2(94)90033-7]
25. Sato H, Goto W, Yamamura J, Kurokawa M, Kageyama S, Takahara T, Watanabe A, Shiraki K. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res 1996; 30: 171-177 [PMID: 8783808 DOI: 10.1016/0166-3542(96)00942-4]
26. Gwak GY, Moon TG, Lee DH, Yoo BC. Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway. World J Gastro-enterol 2012; 18: 679-684 [PMID: 22363140 DOI: 10.3748/wjg. v18.i7.679]
27. Ikeda T, Abe K, Kuroda N, Kida Y, Inoue H, Wake K, Mori-to M, Sato T. The inhibition of apoptosis by glycyrrhizin in hepatic injury induced by injection of lipopolysaccharide/D-galactosamine in mice. Arch Histol Cytol 2008; 71: 163-178 [PMID: 19194039 DOI: 10.1679/aohc.71.163]
28. Tang B, Qiao H, Meng F, Sun X. Glycyrrhizin attenuates endotoxin- induced acute liver injury after partial hepatec-tomy in rats. Braz J Med Biol Res 2007; 40: 1637-1646 [PMID: 17994167 DOI: 10.1590/S0100-879X2006005000173]
29. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tet-rachloride. Am J Pathol 1998; 153: 515-525 [PMID: 9708811 DOI: 10.1016/S0002-9440(10)65594-0]
30. Patella S, Phillips DJ, Tchongue J, de Kretser DM, Sievert W. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 2006; 290: G137-G144 [PMID: 16123203 DOI: 10.1152/ajpgi.00080.2005]
31. Aram G, Potter JJ, Liu X, Wang L, Torbenson MS, Mezey E. Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. Hepatology 2009; 49: 911-919 [PMID: 19072832 DOI: 10.1002/hep.22708]
32. Kuwahata M, Kubota H, Kanouchi H, Ito S, Ogawa A, Ko-bayashi Y, Kido Y. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease. Nutr Res 2012; 32: 522-529 [PMID: 22901560 DOI: 10.1016/j.nutres.2012.06.007]
33. Lee TY, Chang HH, Wang GJ, Chiu JH, Yang YY, Lin HC. Water-soluble extract of Salvia miltiorrhiza ameliorates carbon tetrachloride-mediated hepatic apoptosis in rats. J Pharm Pharmacol 2006; 58: 659-665 [PMID: 16640835 DOI: 10.1211/jpp.58.5.0011]
34. Weiler-Normann C, Herkel J, Lohse AW. Mouse models of liver fibrosis. Z Gastroenterol 2007; 45: 43-50 [PMID: 17236120 DOI: 10.1055/s-2006-927387]
35. Cai Y, Shen XZ, Wang JY. Effects of glycyrrhizin on genes expression during the process of liver fibrosis. Zhonghua Yixue Zazhi 2003; 83: 1122-1125 [PMID: 12921627]
36. Wang JY, Zhang QS, Guo JS, Hu MY. Effects of glycyrrhet-inic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats. World J Gastroenterol 2001; 7: 115-119 [PMID: 11819745]
37. Consensus on evaluation of the diagnosis and efficacy of hepatic fibrosis. Zhonghua Ganzangbing Zazhi 2002; 10: 327-328 [PMID: 12392606]
38. Giannone FA, Baldassarre M, Domenicali M, Zaccherini G, Trevisani F, Bernardi M, Caraceni P. Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis. Lab Invest 2012; 92: 384-395 [PMID: 22184091 DOI: 10.1038/labinvest.2011.191]
39. Mantena SK, Sharma SD, Katiyar SK. Berberine inhibits growth, induces G1 arrest and apoptosis in human epider-moid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006; 27: 2018-2027 [PMID: 16621886 DOI: 10.1093/carcin/bgl043]
40. Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002; 122: 1525-1528 [PMID: 11984538 DOI: 10.1053/gast.2002.33367]
41. Friedman SL, Bansal MB. Reversal of hepatic fibrosis -- fact or fantasy? Hepatology 2006; 43: S82-S88 [PMID: 16447275 DOI: 10.1002/hep.20974]
42. Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, Maurice N, Mukherjee A, Goldbach C, Watkins S, Micha-lopoulos G, Perlmutter DH. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science 2010; 329: 229-232 [PMID: 20522742 DOI: 10.1126/science.1190354]
43. Lee TF, Lin YL, Huang YT. Studies on antiproliferative effects of phthalides from Ligusticum chuanxiong in hepatic stellate cells. Planta Med 2007; 73: 527-534 [PMID: 17520522 DOI: 10.1055/s-2007-981520]
44. Weber LW, Boll M, Stampf A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003; 33: 105-136 [PMID: 12708612 DOI: 10.1080/713611034]
45. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997; 79: 1494-1500 [PMID: 9118029]
46. van Rossum TG, Vulto AG, Hop WC, Brouwer JT, Niesters HG, Schalm SW. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J Gastroenterol Hepatol 1999; 14: 1093-1099 [PMID: 10574137]
47. Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Dig Dis Sci 2005; 50: 1807-1812 [PMID: 16187178 DOI: 10.1007/s10620-005-2942-9]
48. Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137: 609-622 [PMID: 19450511 DOI: 10.1016/j.cell.2009.04.050]
49. Pani G, Fusco S, Colavitti R, Borrello S, Maggiano N, Cravero AA, Farré SM, Galeotti T, Koch OR. Abrogation of hepatocyte apoptosis and early appearance of liver dysplasia in ethanol-fed p53-deficient mice. Biochem Biophys Res Commun 2004; 325: 97-100 [PMID: 15522206 DOI: 10.1016/j.bbrc.2004.09.213]
50. Li W, Laskar A, Sultana N, Osman E, Ghosh M, Li Q, Yuan XM. Cell death induced by 7-oxysterols via lysosomal and mitochondrial pathways is p53-dependent. Free Radic Biol Med 2012; 53: 2054-2061 [PMID: 22985798 DOI: 10.1016/j.fre-eradbiomed.2012.09.007]
51. Sakamoto Y, Kato S, Takahashi M, Okada Y, Yasuda K, Wata-nabe G, Imai H, Sato A, Ishioka C. Contribution of autophagic cell death to p53-dependent cell death in human glioblastoma cell line SF126. Cancer Sci 2011; 102: 799-807 [PMID: 21214676 DOI: 10.1111/j.1349-7006.2011.01857.x]
52. Finkel E. The mitochondrion: is it central to apoptosis? Science 2001; 292: 624-626 [PMID: 11330312 DOI: 10.1126/sci-ence.292.5517.624]
53. Curreli F, Friedman-Kien AE, Flore O. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. J Clin Invest 2005; 115: 642-652 [PMID: 15765147 DOI: 10.1172/JCI23334]
54. 4) and dimethylnitrosamine (DMN). J Histochem Cyto-chem 2000; 48: 1331-1339 [PMID: 10990487]
55. 4 in rats. Arch Med Res 1996; 27: 285-289 [PMID: 8854383]
56. 4 in rats: a pathological investigation]. Nihon Yakurigaku Zasshi 1983; 81: 585-591 [PMID: 6618347]
57. Boncompagni E, Gini E, Ferrigno A, Milanesi G, Gringeri E, Barni S, Cillo U, Vairetti M, Freitas I. Decreased apopto-sis in fatty livers submitted to subnormothermic machine-perfusion respect to cold storage. Eur J Histochem 2011; 55: e40 [PMID: 22297446]
58. Jazwinski AB, Thompson AJ, Clark PJ, Naggie S, Tillmann HL, Patel K. Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not ste-atosis. J Viral Hepat 2012; 19: 278-282 [PMID: 22404726 DOI: 10.1111/j.1365-2893.2011.01546.x]